RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 1, 2015, Pages 87-101

  Hu, Yan Wei ^a   Zhao, Jia Yi ^a   Li, Shu Fen ^a   Huang, Jin Lan ^a   Qiu, Yu Rong ^a   Ma, Xin ^a   Wu, Shao Guo ^a   Chen, Zhi Ping ^a   Hu, Ya Rong ^a   Yang, Jun Yao ^a   Wang, Yan Chao ^a   Gao, Ji Juan ^a   Sha, Yan Hua ^a   Zheng, Lei ^a   Wang, Qian ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; human; long noncoding; NFIA protein; RNA

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIVER X RECEPTOR ALPHA; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA RP5 833A20; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; MICRORNA 382 5P; NUCLEAR FACTOR I; NUCLEAR FACTOR IA; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; AGTR1 PROTEIN, HUMAN; ANGIOTENSIN 1 RECEPTOR; APOLIPOPROTEIN E; AUTACOID; CHOLESTEROL; CYTOKINE; LOW DENSITY LIPOPROTEIN; MIRN382 MICRORNA, HUMAN; NFIA PROTEIN, HUMAN; NFIA PROTEIN, MOUSE; RP5-833A20.1 LONG NON-CODING RNA, MOUSE;

ACUTE MONOCYTIC LEUKEMIA; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL HOMEOSTASIS; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC REGULATION; HOMEOSTASIS; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; CACO 2 CELL LINE; DEFICIENCY; DISEASE MODEL; DNA MICROARRAY; FOAM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HEPG2 CELL LINE; HUMAN; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LENTIVIRINAE; MALE; METABOLISM; PROCEDURES; TIME;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CACO-2 CELLS; CHOLESTEROL; CYTOKINES; DISEASE MODELS, ANIMAL; FOAM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEP G2 CELLS; HOMEOSTASIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LENTIVIRUS; LIPOPROTEINS, LDL; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; NFI TRANSCRIPTION FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84920144487     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304296     Document Type: Article

References (65)

1. Peters SA, den Ruijter HM, Bots ML, Moons KG. Improvements in risk stratifcation for the occurrence of cardiovascular disease by imaging sub-clinical atherosclerosis: a systematic review. Heart. 2012;98:177-184.
2. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
3. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17:1410-1422.
4. Onat D, Brillon D, Colombo PC, Schmidt AM. Human vascular endothe-lial cells: a model system for studying vascular infammation in diabetes and atherosclerosis. Curr Diab Rep. 2011;11:193-202.
5. Ho-Tin-Noé B, Michel JB. Initiation of angiogenesis in atherosclerosis: smooth muscle cells as mediators of the angiogenic response to atheroma formation. Trends Cardiovasc Med. 2011;21:183-187.
6. Martinet W, Schrijvers DM, De Meyer GR. Molecular and cellular mechanisms of macrophage survival in atherosclerosis. Basic Res Cardiol. 2012;107:297.
7. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341-355.
8. Valledor AF, Ricote M. Nuclear receptor signaling in macrophages. Biochem Pharmacol. 2004;67:201-212.
9. Hu YW, Zheng L, Wang Q. Regulation of cholesterol homeostasis by liver X receptors. Clin Chim Acta. 2010;411:617-625.
10. Deneen B, Ho R, Lukaszewicz A, Hochstim CJ, Gronostajski RM, Anderson DJ. The transcription factor NFIA controls the onset of gliogen-esis in the developing spinal cord. Neuron. 2006;52:953-968.
11. Gronostajski RM. Roles of the NFI/CTF gene family in transcription and development. Gene. 2000;249:31-45.
12. Gronostajski RM. Analysis of nuclear factor I binding to DNA using degenerate oligonucleotides. Nucleic Acids Res. 1986;14:9117-9132.
13. Waki H, Nakamura M, Yamauchi T, et al. Global mapping of cell type-specifc open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation. PLoS Genet. 2011;7:e1002311.
14. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet. 2009;5:e1000459.
15. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38.
16. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1:391-407.
17. Hauptman N, Glavac D. Long non-coding RNA in cancer. Int J Mol Sci. 2013;14:4655-4669.
18. Harries LW. Long non-coding RNAs and human disease. Biochem Soc Trans. 2012;40:902-906.
19. Zhang W, Chen Y, Liu P, Chen J, Song L, Tang Y, Wang Y, Liu J, Hu FB, Hui R. Variants on chromosome 9p21.3 correlated with ANRIL expression contribute to stroke risk and recurrence in a large prospective stroke population. Stroke. 2012;43:14-21.
20. Horsthuis T, Houweling AC, Habets PE, de Lange FJ, el Azzouzi H, Clout DE, Moorman AF, Christoffels VM. Distinct regulation of developmental and heart disease-induced atrial natriuretic factor expression by two separate distal sequences. Circ Res. 2008;102:849-859.
21. Annilo T, Kepp K, Laan M. Natural antisense transcript of natriuretic pep-tide precursor A (NPPA): structural organization and modulation of NPPA expression. BMC Mol Biol. 2009;10:81.
22. Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res. 2012;111:1349-1362.
23. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155-159.
24. Katayama S, Tomaru Y, Kasukawa T, et al; RIKEN Genome Exploration Research Group; Genome Science Group (Genome Network Project Core Group); FANTOM Consortium. Antisense transcription in the mammalian transcriptome. Science. 2005;309:1564-1566.
25. Moran VA, Perera RJ, Khalil AM. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res. 2012;40:6391-6400.
26. Lee JT. Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev. 2009;23:1831-1842.
27. Hung T, Wang Y, Lin MF, et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet. 2011;43:621-629.
28. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129:1311-1323.
29. Maamar H, Cabili MN, Rinn J, Raj A. linc-HOXA1 is a noncoding RNA that represses Hoxa1 transcription in cis. Genes Dev. 2013;27:1260-1271.
30. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904-914.
31. Pasmant E, Sabbagh A, Vidaud M, Bièche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011;25:444-448.
32. Hawkins PG, Morris K V. Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. Transcription. 2010;1:165-175.
33. Salmena L, Poliseno L, Tay Y, Kats L, Pandolf PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353-358.
34. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147:358-369.
35. Yoon JH, Abdelmohsen K, Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol. 2013;425:3723-3730.
36. Yu XH, Fu YC, Zhang DW, Yin K, Tang CK. Foam cells in atherosclerosis. Clin Chim Acta. 2013;424:245-252.
37. Atkinson SR, Marguerat S, Bähler J. Exploring long non-coding RNAs through sequencing. Semin Cell Dev Biol. 2012;23:200-205.
38. Liao Q, Liu C, Yuan X, Kang S, Miao R, Xiao H, Zhao G, Luo H, Bu D, Zhao H, Skogerbø G, Wu Z, Zhao Y. Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res. 2011;39:3864-3878.
39. Janga SC, Vallabhaneni S. MicroRNAs as post-transcriptional machines and their interplay with cellular networks. Adv Exp Med Biol. 2011;722:59-74.
40. Zhao Y, He S, Liu C, Ru S, Zhao H, Yang Z, Yang P, Yuan X, Sun S, Bu D, Huang J, Skogerbø G, Chen R. MicroRNA regulation of messenger-like noncoding RNAs: a network of mutual microRNA control. Trends Genet. 2008;24:323-327.
41. Lee S, Vasudevan S. Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol. 2013;768:97-126.
42. de Planell-Saguer M, Rodicio MC. Analytical aspects of microRNA in diagnostics: a review. Anal Chim Acta. 2011;699:134-152.
43. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, Sun F, Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38:5366-5383.
44. Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G, Lu X. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal. 2013;25:1086-1095.
45. Zhao X, Tang Z, Zhang H, et al. A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons. Nat Neurosci. 2013;16:1024-1031.
46. Tabas I. Cholesterol and phospholipid metabolism in macrophages. Biochim Biophys Acta. 2000;1529:164-174.
47. Ouimet M, Marcel YL. Regulation of lipid droplet cholesterol effux from macrophage foam cells. Arterioscler Thromb Vasc Biol. 2012;32:575-581.
48. Stefulj J, Panzenboeck U, Becker T, Hirschmugl B, Schweinzer C, Lang I, Marsche G, Sadjak A, Lang U, Desoye G, Wadsack C. Human endothelial cells of the placental barrier effciently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res. 2009;104:600-608.
49. Ohashi R, Mu H, Wang X, Yao Q, Chen C. Reverse cholesterol transport and cholesterol effux in atherosclerosis. QJM. 2005;98:845-856.
50. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA. 2002;99:16237-16242.
51. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;303:1201-1204.
52. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991;353:265-267.
53. Navab KD, Elboudwarej O, Gharif M, Yu J, Hama SY, Safarpour S, Hough GP, Vakili L, Reddy ST, Navab M, Vaziri ND. Chronic infammatory disorders and accelerated atherosclerosis: chronic kidney disease. Curr Pharm Des. 2011;17:17-20.
54. Fitzgerald ML, Mujawar Z, Tamehiro N. ABC transporters, atherosclerosis and infammation. Atherosclerosis. 2010;211:361-370.
55. Libby P. Infammation in atherosclerosis. Nature. 2002;420:868-874.
56. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol. 2009;29:1419-1423.
57. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13:709-721.
58. Getz GS, Reardon CA. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:1104-1115.
59. Curtiss LK, Boisvert WA. Apolipoprotein E and atherosclerosis. Curr Opin Lipidol. 2000;11:243-251.
60. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-defcient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
61. Meir KS, Leitersdorf E. Atherosclerosis in the apolipoprotein-E-defcient mouse: a decade of progress. Arterioscler Thromb Vasc Biol. 2004;24:1006-1014.
62. Sanan DA, Newland DL, Tao R, Marcovina S, Wang J, Mooser V, Hammer RE, Hobbs HH. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a). Proc Natl Acad Sci USA. 1998;95:4544-4549.
63. Breslow JL. Mouse models of atherosclerosis. Science. 1996;272:685-688.
64. Zadelaar S, Kleemann R, Verschuren L, de Vries-Van der Weij J, van der Hoorn J, Princen HM, Kooistra T. Mouse models for atherosclerosis and pharmaceutical modifers. Arterioscler Thromb Vasc Biol. 2007;27:1706-1721.
65. Vu-Dac N, Chopin-Delannoy S, Gervois P, Bonnelye E, Martin G, Fruchart JC, Laudet V, Staels B. The nuclear receptors peroxisome prolif-erator-activated receptor alpha and Rev-erbalpha mediate the species-spe-cifc regulation of apolipoprotein A-I expression by fbrates. J Biol Chem. 1998;273:25713-25720.